Las Vegas, NV -- (SBWIRE) -- 12/31/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE), Glu Mobile Inc. (NASDAQ:GLUU), na Biopharma Inc (NASDAQ:GALE)
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) managed to keep its fall at -4.85% on below -normal volume of 3.14M shares. The stock settled at $0.980 after floating in a range of $0.95 to $103. Its latest price has reached market capitalization of $55.95 million. Its 52-week range has been $0.65 to $4. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.
Has IMUC Found The Bottom and Ready To Move Up? Find Out Here
Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) traded up on a volume of 6.91 million, higher than its standard daily volume. Shares have gained 8.16% to $5.17. Over the last twelve months, the stock has gained 120% and faced a worst price of $1.62. Yingli Green Energy Holding Company Limited is a vertically integrated photovoltaic (PV), product manufacturer worldwide. The Company designs, manufactures and sells PV modules, and design, assemble, sell and install PV systems. Its products and services substantially cover the entire PV industry value chain, ranging from crystalline polysilicon ingots and wafers, PV cells and PV modules to the manufacture of PV systems and the installation of PV systems.
For How Long YGE’s Gloss will Attract Investors? Find out via this report
Glu Mobile Inc. (NASDAQ:GLUU) settled 4.36% higher at $3.83 on above-normal volume of 2.71M shares during the last trading day. The stock has its 12-month high at $4.14 and 52-week low price was $2. It traded in a range of $3.67 to $3.85 during the last trading day. Glu Mobile Inc. (Glu) designs, markets and sells mobile games. The Company has developed and published a portfolio of action/adventure and casual games designed to appeal to a cross section of the users of smartphones and tablet devices who purchase its games through direct-to-consumer digital storefronts, as well as users of feature phones served by wireless carriers and other distributors.
Why Should Investors Buy GLUU After the Recent Fall? Just Go Here and Find Out
In the last trading session, Galena Biopharma Inc (NASDAQ:GALE) was up on high volume, trading at a volume of 6.89M shares versus its average daily volume of 6.03 million shares. At $4.82, the stock has attained market capitalization of $507.24 million. Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics.
Why Should Investors Buy GALE After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)